Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.49.2.783-787.2005PMID 15673768PMCID PMC547350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

  2004cited by this paper
• Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.

  2004cited by this paper
• Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002

  2004cited by this paper
• Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis

  2004influential reference
• Functional Genomic Analysis of Fluconazole Susceptibility in the Pathogenic Yeast Candida glabrata: Roles of Calcium Signaling and Mitochondria

  2004cited by this paper
• Function of Candida glabrata ABC transporter gene, PDH1

  2003cited by this paper
• Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation

  2003influential reference
• Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.

  2002cited by this paper
• Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study

  2002cited by this paper
• Evolution of Drug Resistance in Experimental Populations of Candida albicans

  2000cited by this paper
• Upregulation of ERG Genes inCandida Species by Azoles and Other Sterol Biosynthesis Inhibitors

  2000cited by this paper
• In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.

  1999cited by this paper
• The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents

  1999cited by this paper
• Rapid Identification of Candida Species with Species-Specific DNA Probes

  1998cited by this paper
• Rapid, Transient Fluconazole Resistance inCandida albicans Is Associated with Increased mRNA Levels of CDR

  1998cited by this paper
• Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, inCandida glabrata

  1998cited by this paper
• The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans

  1997cited by this paper
• Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus

  1997cited by this paper
• Molecular biological characterization of an azole-resistant Candida glabrata isolate

  1997cited by this paper
• The epidemiology of hematogenous candidiasis caused by different Candida species.

  1997cited by this paper
• Reversible fluconazole resistance in Candida albicans: a potential in vitro model

  1997cited by this paper
• Development and verification of fingerprinting probes for Candida glabrata.

  1997cited by this paper
• Multiple Pdr1p/Pdr3p Binding Sites Are Essential for Normal Expression of the ATP Binding Cassette Transporter Protein-encoding Gene PDR5*

  1996cited by this paper
• The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

  1996cited by this paper
• Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

  1993cited by this paper
• Fluconazole resistance in Candida glabrata

  1993cited by this paper
• Fluconazole resistance in Candida glabrata.

  1988cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Emergence of invasive candidiasis with multiple Candida species exhibiting azole and echinocandin resistance

  2025cites this paper
• A small Candida glabrata protein promotes hyphal growth in C. albicans during mixed-species invasive candidiasis.

  2025cites this paper
• Agrochemical fungicides as environmental drivers of antifungal resistance.

  2025cites this paper
• Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates

  2024cites this paper
• Long-term stability of acquired drug resistance and resistance associated mutations in the fungal pathogen Nakaseomyces glabratus (Candida glabrata)

  2024cites this paper
• Genome‐wide profiling of piggyBac transposon insertion mutants reveals loss of the F1F0 ATPase complex causes fluconazole resistance in Candida glabrata

  2024cites this paper
• Fungemia in Hospitalized Adult Patients with Hematological Malignancies: Epidemiology and Risk Factors

  2023cites this paper
• Antitumoral and Antimicrobial Activities of Block Copolymer Micelles Containing Gold Bisdithiolate Complexes

  2023cites this paper
• Mechanisms of Azole Resistance in CandidaA Narrative Review

  2023cites this paper
• Antifungal Susceptibility Pattern of Candida glabrata from a Referral Center and Reference Laboratory: 2012–2022

  2023cites this paper
• Broad Spectrum Functional Activity of Structurally Related Monoanionic Au(III) Bis(Dithiolene) Complexes

  2022cites this paper
• The Role of ERG11 Point Mutations in the Resistance of Candida albicans to Fluconazole in the Presence of Lactate

  2022cites this paper
• Recent Trends in the Epidemiology of Fungal Infections.

  2021cites this paper
• Resistance to Antifungal Drugs.

  2021cites this paper
• Transcriptome Analysis Unveils Gln3 Role in Amino Acids Assimilation and Fluconazole Resistance in Candida glabrata

  2021cites this paper
• Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

  2021cites this paper
• Pilzinfektionen in der Intensivmedizin

  2021cites this paper
• Immunotherapy and Antifungal Drugs of Candidiasis: Achievements and Challenges

  2021cites this paper
• Dermatophytes develop resistance to the monoterpenes geraniol and citronellol

  2020cites this paper
• 1H, 13C, 15 N chemical shift assignments of the FKBP12 protein from the pathogenic fungi Candida auris and Candida glabrata

  2020cites this paper
• Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

  2020cites this paper
• Dynamics of in-vitro development of azole resistance in Candida tropicalis.

  2020cites this paper
• Pilzinfektionen in der Intensivmedizin

  2020cites this paper
• Aneuploidy Enables Cross-Adaptation to Unrelated Drugs

  2019cites this paper
• Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata.

  2019cites this paper
• Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection

  2019cites this paper
• Inflammatory Cell Recruitment in Candida glabrata Biofilm Cell-Infected Mice Receiving Antifungal Chemotherapy

  2019cites this paper
• Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases.

  2019cites this paper
• Multidrug-resistant Candida glabrata strains obtained by induction of anidulafungin resistance in planktonic and biofilm cells

  2019cites this paper
• On the path to gold: Monoanionic Au bisdithiolate complexes with antimicrobial and antitumor activities.

  2019cites this paper
• Attenuating the emergence of anti-fungal drug resistance by harnessing synthetic lethal interactions in a model organism

  2019cites this paper
• Impact of the Major Candida glabrata Triazole Resistance Determinants on the Activity of the Novel Investigational Tetrazoles VT-1598 and VT-1161

  2019cites this paper
• Mechanisms of azole resistance in clinical isolates of Candida glabrata from two hospitals in China

  2019cites this paper
• ABC and MFS Transporters: A reason for Antifungal drug resistance

  2018cites this paper
• Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata

  2018cites this paper
• Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium

  2018cites this paper
• Clinical Significance of the Floral Shift in Candidiasis.

  2018cites this paper
• Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients

  2017cites this paper
• Studying mechanisms of antifungal resistance in Candida glabrata clinical isolates: emphasis on the role of the CgPdr1 transcription factor

  2017cites this paper
• Potassium Uptake Mediated by Trk1 Is Crucial for Candida glabrata Growth and Fitness

  2016cites this paper
• Mechanisms of Antifungal Drug Resistance.

  2015cites this paper
• Candida glabrata: un patógeno emergente

  2015cites this paper
• Studies on the effect of thymoquinone on oxidative stress and cell wall integrity of Candida glabrata

  2015cites this paper
• Association of ADH 1 and DDR 48 expression with azole resistance in Candida albicans

  2015cites this paper
• In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp.

  2015influential citation
• Genomic analysis of a Candida glabrata clinical isolate resistant to antifungals unveils novel features of drug resistance in this pathogenic yeast

  2015cites this paper
• Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms

  2015cites this paper
• Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2*

  2015cites this paper
• Unveiling the mechanisms of evolution towards fluconazole resistance of a Candida glabrata clinical isolate : a transcriptomics approach

  2015cites this paper
• Membrane proteome-wide response to the antifungal drug clotrimazole in Candida glabrata : role of the transcription factor CgPdr 1 and the Drug : H +

  2014cites this paper
• Systematic Phenotyping of a Large-Scale Candida glabrata Deletion Collection Reveals Novel Antifungal Tolerance Genes

  2014cites this paper
• Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

  2014cites this paper
• One Small Step for a Yeast - Microevolution within Macrophages Renders Candida glabrata Hypervirulent Due to a Single Point Mutation

  2014cites this paper
• Epidemiology of Invasive Candidiasis and Challenges for the Mycology Laboratory: Specificities of Candida glabrata

  2014cites this paper
• Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata

  2014cites this paper
• Antifungal drug resistance in Candida species.

  2014cites this paper
• Biowaiver monograph for immediate-release solid oral dosage forms: fluconazole.

  2014cites this paper
• Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014

  2014cites this paper
• Environmental azole fungicide, prochloraz, can induce cross-resistance to medical triazoles in Candida glabrata.

  2014cites this paper
• Fatal Case of Candidemia due to Candida glabrata

  2014cites this paper
• Local silencing controls the oxidative stress response and the multidrug resistance in Candida glabrata

  2013cites this paper
• Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross‐resistance to triazole antifungal agents

  2012cites this paper
• Relationship between respiration deficiency and azole resistance in clinical Candida glabrata.

  2012cites this paper
• Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan.

  2012cites this paper
• The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy

  2012cites this paper
• Perfil fenotípico, diferenciação molecular, produção de enzimas e sensibilidade aos antifúngicos de amostras de leveduras isoladas em três grupos amostrais: mulheres assintomáticas, com candidíase vulvovaginal primária e recorrente

  2012cites this paper
• Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.

  2012cites this paper
• Candida glabrata: Multidrug Resistance and Increased Virulence in a Major Opportunistic Fungal Pathogen

  2012influential citation
• Identification of two yeast strains from oil-polluted environment by RFLP on ITS-5.8S rDNA and RAPD analyses

  2012cites this paper
• Voriconazole in clinical practice

  2012cites this paper
• The Epidemiology of Invasive Candidiasis

  2012cites this paper
• Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata

  2011cites this paper
• Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.

  2011cites this paper
• Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.

  2011cites this paper
• Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.

  2011cites this paper
• The Effect of Cumulative Length of Hospital Stay on the Antifungal Resistance of Candida Strains Isolated from Critically Ill Surgical Patients

  2010cites this paper
• Antifungal Susceptibility of Candida Species and Cryptococcus Neoformans Isolated from Patients at the Komfo Anokye Teaching Hospital in Kumasi

  2010cites this paper
• Resistance to Antifungal Agents

  2010cites this paper
• Transcriptional regulation of azole antifungal resistance and tolerance in Candida glabrata

  2010cites this paper
• Regulation of multidrug resistance in pathogenic fungi.

  2010cites this paper
• Typing of Candida isolates from patients with invasive infection and concomitant colonization

  2010cites this paper
• Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex

  2010cites this paper
• Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

  2010cites this paper
• Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex.

  2010cites this paper
• Efflux in Fungi: La Pièce de Résistance

  2009cites this paper
• Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

  2009cites this paper
• Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?

  2009cites this paper
• Efflux-Mediated Antifungal Drug Resistance

  2009cites this paper
• New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance

  2009cites this paper
• Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.

  2008cites this paper
• Emergence of Resistance to Amphotericin B and Triazoles in Candida glabrata Vaginal Isolates in a Case of Recurrent Vaginitis

  2008cites this paper
• Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi.

  2008cites this paper
• Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.

  2008cites this paper
• Non-albicans Candida infections.

  2008cites this paper
• Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

  2007cites this paper
• The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia

  2007cites this paper
• [In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].

  2007cites this paper
• Changes in Karyotype and Azole Susceptibility of Sequential Bloodstream Isolates from Patients with Candida glabrata Candidemia

  2007cites this paper
• Voriconazole and multidrug resistance in Candida albicans

  2007cites this paper
• Selection of a Surrogate Agent (Fluconazole or Voriconazole) for Initial Susceptibility Testing of Posaconazole against Candida spp.: Results from a Global Antifungal Surveillance Program

  2007influential citation